Liberty Biopharma (CVE:LTY) Stock Crosses Above Fifty Day Moving Average of $2.00

Liberty Biopharma Inc (CVE:LTYGet Free Report)’s stock price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.

Liberty Biopharma Trading Up ∞

The stock has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12. The company’s 50 day simple moving average is C$2.00 and its two-hundred day simple moving average is C$2.00.

Liberty Biopharma Company Profile

(Get Free Report)

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.

See Also

Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with's FREE daily email newsletter.